Indefinite Delivery Contract SPE2D018D0005

Award Date 1/17/18
Last Date to Order 1/16/28
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award with ID SPE2DE21D0007 was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The single-award, indefinite delivery contract has a ceiling value of $49,500,000 and a period of performance through December 9, 2025. The contract is to procure a wide range of laboratory supplies, including reagents, diagnostics, chemicals, biologicals, apparatus, equipment, and instruments, for use by Department of...
This federal contract IDV was awarded by the Department of the Army Medical Command to Ortho-Clinical Diagnostics Inc., a for-profit medical equipment manufacturer and supplier. The contract, valued at $1,050,000, is for the provision of in vitro diagnostic reagents and test kits over a multi-year period ending September 30, 2020. This single-award IDV allows the Army Medical Command flexibility to issue delivery orders for Ortho-Clinical Diagnostics' clinical chemistry analyzers, immunoassay...
This federal Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs, Veterans Integrated Service Network 23 to Ortho-Clinical Diagnostics, Inc., a for-profit organization and self-certified HUBZone joint venture that manufactures medical equipment and diagnostic solutions. The $120,000 single-award contract, with a period of performance through March 31, 2027, is for the delivery of CPRR lab supplies. Ortho-Clinical Diagnostics has provided similar products...
The Department of Defense's Defense Health Agency awarded Ortho-Clinical Diagnostics Inc. an indefinite-delivery/indefinite-quantity contract with a potential value of $2,655,406.12 to provide orthovision reagents and consumables. The contract has a period of performance from June 1, 2020 through September 30, 2024. Under the contract, Ortho-Clinical Diagnostics Inc. has received five delivery orders to date for orthovision reagents and consumables from the Defense Health Agency and...
This federal contract IDV award from the Department of the Army Medical Command (MEDCOM) to Ortho-Clinical Diagnostics Inc. provides for the delivery of automated in vitro reagents to support the medical testing needs of various military treatment facilities. The single-award indefinite delivery contract, valued at $1,052,500, has a period of performance from October 2020 to September 2023. Under this IDV, Ortho-Clinical Diagnostics has received multiple firm fixed price delivery orders to...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Health Agency (DHA), a defense agency, to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer. The IDC, valued at $2,282,162.15, is for the procurement of immunoassay testing and related services over a period ending on March 30, 2029. The contract was not set aside for any particular business category. It is a single-award IDC to provide waterless integrated chemistry and immunoassay analyzers, reagents,...
The Department of Veterans Affairs Veterans Health Administration (VA-VHA) awarded an Indefinite Delivery Contract to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer, to provide ORTHO BLOOD BANK REAGENTS. The single-award, five-year contract has a potential value of $1,456,996.34 and runs from July 1, 2023 through June 30, 2028. Under this contract, Ortho-Clinical Diagnostics will deliver blood bank reagents to support VA-VHA healthcare programs serving veterans in northern...
This indefinite delivery contract, awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., provides reagents and consumables for government-owned Ortho Vision Analyzers in support of the BDAACH location in Korea. The $771,818.90 contract has a period of performance from October 1, 2024 to September 30, 2029. The contract was not set aside for any particular business size or type. It is a single-award indefinite delivery vehicle, allowing for the placement of firm-fixed price...
Ortho-Clinical Diagnostics Inc. holds a Federal Supply Schedule (FSS) contract (GS24F1243C) with the U.S. federal government, which enables various agencies to efficiently procure the company's medical equipment, reagents, and diagnostic services. Under this IDV, Ortho-Clinical Diagnostics has received numerous delivery orders from agencies such as the Indian Health Service, Department of Veterans Affairs, and Air Force Materiel Command for products including clinical chemistry analyzers,...
This indefinite delivery contract was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 to Ortho-Clinical Diagnostics, Inc., a manufacturer of medical diagnostic equipment and consumables. The $1.5 million contract provides blood bank gel cards, reagents, and consumables to support VA healthcare programs through February 2029. The first task order, valued at $84,455.85, was issued on March 1, 2024 for delivery of these supplies to a location in Raritan,...
  • SPE2D018D0005
    Indefinite Delivery Contract
  • 1.3K
    Federal Contract Awards

The Defense Logistics Agency (DLA) Troop Support Medical awarded an indefinite-delivery contract (IDC) with ID number SPE2D018D0005 to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturing company and self-certified HUBZone joint venture. The $9,790,074.33 contract, which does not utilize any set-asides, has an ultimate completion date of January 16, 2028. Under this IDC, Ortho-Clinical Diagnostics is providing a variety of medical equipment, reagents, and testing services to support federal healthcare programs, primarily for the Department of Defense.

Task orders issued to date include firm fixed-price deliveries of reagents such as anti-A, anti-D, and anti-IGG bioclone, as well as pharmaceutical products like Phenytoin. The total ceiling values of these individual task orders range from $43 to $30,375. The place of performance for the contracted items is Ortho-Clinical Diagnostics' facility in Raritan, New Jersey. As a manufacturer of diagnostic solutions, Ortho-Clinical Diagnostics has long-standing relationships with several federal agencies, including the Department of Veterans Affairs, Defense Health Agency, and Indian Health Service, providing critical laboratory equipment, reagents, and blood bank services under both competitive and sole-source awards.

Generated 9/3/24, 12:02 PM